NA
MEDP icon

Navellier & Associates’s Medpace MEDP Stock Holding History

Navellier & Associates’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6,553
Closed -$610K – 250
2020
Q2 		$610K Sell
6,553
-9,036
-58% -$769K 0.15% 120
2020
Q1 		$1.14M Sell
15,589
-1,000
-6% -$86.8K 0.27% 85
2019
Q4 		$1.39M Sell
16,589
-365
-2% -$28.3K 0.22% 112
2019
Q3 		$1.43M Buy
16,954
+7,283
+75% +$550K 0.24% 108
2019
Q2 		$633K Sell
9,671
-124
-1% -$7.15K 0.1% 169
2019
Q1 		$578K Buy
9,795
+5,095
+108% +$304K 0.09% 154
2018
Q4 		$249K Buy
+4,700
New +$258K 0.04% 193

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Navellier & Associates's MEDP Position: Q3 2020 in Review

Navellier & Associates sold out of Medpace (MEDP) in Q3 2020, closing a stake of 6,553 shares — an estimated $610K sold.

Navellier & Associates first reported a position in MEDP in Q4 2018 and held it in 7 quarters. The position peaked at $1.43M in Q3 2019. 310 funds tracked by Wall St. Rank hold MEDP as of Q3 2020.

  • Navellier & Associates reported no remaining Medpace position as of Q3 2020 after selling out during the quarter.
  • Navellier & Associates sold 6,553 Medpace shares in Q3 2020, an estimated $610K.
  • Navellier & Associates first reported a position in Medpace in Q4 2018 and held it in 7 quarters.
  • Navellier & Associates's Medpace position peaked at $1.43M in Q3 2019.
  • 310 funds tracked by Wall St. Rank held Medpace as of Q3 2020.

Based on Navellier & Associates's 13F filing for Q3 2020, filed 9 Nov 2020.